Health

Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

DailyTrendDailyTrend
Oct 24, 2025 - 00:00
 0  1
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Testosterone Is Giving Women Back Their Sex Drive but R...

DailyTrend Oct 22, 2025  0  1

What Happens if Obamacare Subsidies Expire?

What Happens if Obamacare Subsidies Expire?

DailyTrend Oct 22, 2025  0  1

U.S. Health Workers Recalled From Shutdown Furlough for Medicare, A.C.A. Enrollments

U.S. Health Workers Recalled From Shutdown Furlough for...

DailyTrend Oct 24, 2025  0  1

Workers and Employers Face Higher Health Insurance Costs

Workers and Employers Face Higher Health Insurance Costs

DailyTrend Oct 22, 2025  0  1

Three Cases of Mpox Tied to Severe Illness Worry Health Experts

Three Cases of Mpox Tied to Severe Illness Worry Health...

DailyTrend Oct 17, 2025  0  1

Family Health Insurance Coverage Nears $27,000 a Year

Family Health Insurance Coverage Nears $27,000 a Year

DailyTrend Oct 24, 2025  0  1